microMend Overview
- Founded
-
2010

- Status
-
Private
- Employees
-
14

- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$18M
- Investors
-
17
microMend General Information
Description
Developer of wound closure product designed to offer a new alternative to sutures and staples for skin closure. The company's product has the added feature of tiny micro staples that assist it to achieve similar holding strength to sutures and close wounds, enabling medical practitioners to close surgical incisions, lacerations, and skin tears.
Contact Information
Website
www.micromendskinclosure.com
Formerly Known As
Marco Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Primary Office
- 500 Yale Avenue North
- Suite 100
- Seattle, WA 98109
- United States
+1 (877) 000-0000
microMend Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Later Stage VC (Series B) | 07-Dec-2021 | $18M | 000.00 | 000.00 | Completed | Generating Revenue |
5. Later Stage VC (Series A1) | 02-Mar-2017 | 00000 | 00.000 | 00.00 | Completed | Generating Revenue |
4. Angel (individual) | 31-Dec-2015 | 00.000 | Completed | Generating Revenue | ||
3. Early Stage VC (Series A) | 23-Dec-2014 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
2. Grant | 01-Dec-2012 | $1.75M | $15K | Completed | Generating Revenue | |
1. Early Stage VC | 01-Jan-2010 | $15K | $15K | Completed | Startup |
microMend Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B-3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.00 | |
Series B-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series B-1 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series B | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Series A1 | 809,990 | $0.000100 | $0.9 | $0.9 | 1x | $0.9 | 3.37% | |
Series A | 4,587,757 | $0.000100 | $0.61 | $0.61 | 1x | $0.61 | 19.09% |
microMend Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of wound closure product designed to offer a new alternative to sutures and staples for skin closure. The comp
Medical Supplies
Seattle, WA
14
As of 2021
000.00
00.00
0000-00-00
00000000000
000.00
microMend Competitors (18)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Aspen Surgical | Private Equity-Backed | Caledonia, MI | 0000 | 00000 | 0000000 0000 | |
0000000 | Venture Capital-Backed | San Luis Obispo, CA | 00 | 000.00 | 00000000000 | 000.00 |
000000 0000000 | Private Equity-Backed | Raleigh, NC | 00 | 00000 | 0000000000. | |
000000000 0000000 | Venture Capital-Backed | Corvallis, OR | 00.000 | 000000000 | 00.000 | |
0000000 | Venture Capital-Backed | Paris, France | 00 | 00000 | 00000000000 | 00000 |
microMend Patents
microMend Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220240935-A1 | Wound closure device with wide spaced microstructures | Pending | 29-Jan-2021 | 0000000000 | |
US-20210252256-A1 | Microstructures to attach appliances to tissues | Pending | 19-Feb-2020 | 000000000 | |
EP-4106638-A1 | Wound closure device for wide treatment areas | Pending | 19-Feb-2020 | 0000000000 | |
US-20210251628-A1 | Elastic and flexible wound closure device | Pending | 19-Feb-2020 | 0000000000 | 00 |
US-20210252264-A1 | Microstructure systems and methods for pain treatment | Pending | 19-Feb-2020 | A61M37/0015 |
microMend Executive Team (5)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Ronald Berenson MD | Co-Founder, President, Chief Executive Officer and Board Member | ||
Eli Sonkin | Chief Financial Officer |
microMend Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Cameron Pollock | Self | Board Member | 000 0000 |
Edward Truitt JD | Self | Chairman | 000 0000 |
Henry Kim | Self | Board Member | 000 0000 |
Jens Quistgaard Ph.D | Self | Board Member | 000 0000 |
John Brzezenski | Self | Board Member | 000 0000 |
microMend Signals
microMend Investors (17)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Caygan Capital | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Elevate Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Keiretsu Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Kyto Technology And Life Science | Corporation | Minority | 000 0000 | 000000 0 | |
Michigan Capital Network Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |